A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors.

Singh, Desh Deepak; Han, Ihn; Choi, Eun-Ha; Yadav, Dharmendra Kumar

Singh, Desh Deepak; Han, Ihn; Choi, Eun-Ha; Yadav, Dharmendra Kumar.

Afiliação

Singh DD; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur 303002, India.
Han I; Plasma Bioscience Research Center, Applied Plasma Medicine Center, Department of Electrical & Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
Choi EH; Plasma Bioscience Research Center, Applied Plasma Medicine Center, Department of Electrical & Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
Yadav DK; Department of R&D Center, Arontier Co., Seoul 06735, Republic of Korea.

Curr Issues Mol Biol ; 45(1): 400-433, 2023 Jan 04.

Article em En | MEDLINE | ID: mdl-36661514

Palavras-chave

SARS-CoV-2; antibody; drug treatment; efficacy; neutralization therapy; treatment; variant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Curr Issues Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google